Mizuho Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$4.98K 20
2025
Q4
$4.98K Buy
200
+130
+186% +$3.28K 0.07% 13
2025
Q3
$1.78K Buy
+70
New +$1.73K 0.01% 41
2024
Q3
Sell
-4,500
Closed -$126K 92
2024
Q2
$126K Buy
+4,500
New +$124K 0.29% 41
2024
Q1
Sell
-3,700
Closed -$107K 79
2023
Q4
$107K Buy
3,700
+2,677
+262% +$80.9K 0.38% 34
2023
Q3
$33.9K Buy
+1,023
New +$36.2K 0.16% 48
2023
Q1
Sell
-1,190
Closed -$61K 86
2022
Q4
$61K Buy
1,190
+963
+424% +$46.2K 0.17% 51
2022
Q3
$10K Sell
227
-1,156
-84% -$56.2K ﹤0.01% 88
2022
Q2
$82K Buy
1,383
+959
+226% +$48.9K 0.02% 59
2022
Q1
$22K Sell
424
-21
-5% -$1.09K ﹤0.01% 94
2021
Q4
$26K Sell
445
-1,578
-78% -$78.2K 0.01% 76
2021
Q3
$87K Sell
2,023
-1,860
-48% -$82.4K 0.03% 69
2021
Q2
$152K Buy
3,883
+3,659
+1,633% +$142K 0.03% 61
2021
Q1
$8K Sell
224
-6,458
-97% -$229K ﹤0.01% 89
2020
Q4
$246K Buy
+6,682
New +$245K 0.05% 31
2020
Q1
Sell
-5,344
Closed -$199K 109
2019
Q4
$199K Buy
5,344
+3,131
+141% +$112K 0.11% 54
2019
Q3
$75K Sell
2,213
-2,846
-56% -$103K 0.05% 92
2019
Q2
$208K Buy
+5,059
New +$201K 0.27% 44
2019
Q1
Sell
-664
Closed -$27K 139
2018
Q4
$27K Buy
+664
New +$27.6K ﹤0.01% 97

Other funds holding PFE

Mizuho Securities's PFE Position: Q1 2026 in Review

Mizuho Securities sold out of Pfizer (PFE) in Q1 2026, closing a stake of 200 shares — an estimated $4.98K sold.

Mizuho Securities first reported a position in PFE in Q4 2018 and held it in 18 quarters. The position peaked at $246K in Q4 2020. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Mizuho Securities reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Mizuho Securities sold 200 Pfizer shares in Q1 2026, an estimated $4.98K.
  • Mizuho Securities first reported a position in Pfizer in Q4 2018 and held it in 18 quarters.
  • Mizuho Securities's Pfizer position peaked at $246K in Q4 2020.
  • 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Mizuho Securities's 13F filing for Q1 2026, filed 7 May 2026.